Abstract:Objective: To investigate the effects of Rosuvastatin on the proliferation of adipose-derived mesenchymal stem cells (AD-MSCs)after hypoxia/reoxygenation (H/R) injury. Methods: AD-MSCs were isolated from Kunming mice and characterized by flowcytometry. AD-MSCs were divided into three groups: (1) control,(2) Hypoxia 6hrs+ Reoxygen 42hrs (H/R), (3) H/R+Rosuvastatin (10-8,10-7,10-6mol/L respectively). Cell proliferation was detected by MTT assays. The protein expressions of Akt, Akt, Erk and pErk were analyzed by Western blot assay. Results: The CD44 and CD90 of AD-MSCs were positive. Administration of Rosuvastatin in- creased proliferation of AD-MSCs after H/R injury (P<0.05). Western blot assay revealed that the levels of phosphorylated Akt and phos- phorylated Erk were higher in Rosuvastatin group than that in H/R group. Conclusion: Rosuvastatin promoted the proliferation of AD-MSCs after H/R injury by AKT and ERK.

Rosuvastatin Prevents Adipose-derived Mesenchymal Stem Cells from Hypoxia/Reoxygenation Injury through Activation of ERK and AKT